Direct observation of secondary nucleation along the fibril surface of the amyloid β 42 peptide
Proceedings of the National Academy of Sciences · 20.06.2023 · 120 (25)
DOI: 10.1073/pnas.2220664120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 12.06.2023. Verfasst von Dev Thacker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Structural Biology, Lund University, 22100 Lund, Sweden. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease. Die Arbeit wurde bisher 49-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Knut och Alice Wallenbergs Stiftelse, Alzheimerfonden.
Abstract (Originalsprache)
Alzheimer’s disease is a neurodegenerative condition which involves heavy neuronal cell death linked to oligomers formed during the aggregation process of the amyloid β peptide 42 (A β 42). The aggregation of A β 42 involves both primary and secondary nucleation. Secondary nucleation dominates the generation of oligomers and involves the formation of new aggregates from monomers on catalytic fibril surfaces. Understanding the molecular mechanism of secondary nucleation may be crucial in developing a targeted cure. Here, the self-seeded aggregation of WT A β 42 is studied using direct stochastic optical reconstruction microscopy (dSTORM) with separate fluorophores in seed fibrils and monomers. Seeded aggregation proceeds faster than nonseeded reactions because the fibrils act as catalysts. The dSTORM experiments show that monomers grow into relatively large aggregates on fibril surfaces along the length of fibrils before detaching, thus providing a direct observation of secondary nucleation and growth along the sides of fibrils. The experiments were repeated for cross-seeded reactions of the WT A β 42 monomer with mutant A β 42 fibrils that do not catalyze the nucleation of WT monomers. While the monomers are observed by dSTORM to interact with noncognate fibril surfaces, we fail to notice any growth along such fibril surfaces. This implies that the failure to nucleate on the cognate seeds is not a lack of monomer association but more likely a lack of structural conversion. Our findings support a templating role for secondary nucleation, which can only take place if the monomers can copy the underlying parent structure without steric clashes or other repulsive interactions between nucleating monomers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Structural Biology, Lund University, 22100 Lund, Sweden.
- Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, 22100 Lund, Sweden.
- Department of Chemistry and Applied Biosciences, ETH Zürich, 8093 Zürich, Switzerland.
- NanoLund Center for NanoScience, Lund University, 22100 Lund, Sweden.
ORCID-Profile: Dev Thacker, Mohammad Barghouth, Enming Zhang, Sara Linse
Förderung
- Vetenskapsrådet
- Knut och Alice Wallenbergs Stiftelse
- Alzheimerfonden
- Insamlingsstiftelsen Diabetes Wellness Network Sverige
Zitieren
APA
Thacker, D., Barghouth, M., Bless, M., Zhang, E., & Linse, S. (2023). Direct observation of secondary nucleation along the fibril surface of the amyloid β 42 peptide. Proceedings of the National Academy of Sciences, 120(25). https://doi.org/10.1073/pnas.2220664120
Vancouver
Thacker D, Barghouth M, Bless M, Zhang E, Linse S. Direct observation of secondary nucleation along the fibril surface of the amyloid β 42 peptide. Proceedings of the National Academy of Sciences. 2023;120(25). doi:10.1073/pnas.2220664120
BibTeX
@article{Thacker2023,
author = {Thacker, Dev and Barghouth, Mohammad and Bless, Mara and Zhang, Enming and Linse, Sara},
title = {Direct observation of secondary nucleation along the fibril surface of the amyloid β 42 peptide},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {25},
doi = {10.1073/pnas.2220664120}
}
EUVIMED